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Inappropriate Use of Nonpsychotropic Medications in 
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OBJECTIVES: To determine the prevalence and patient- 
specific predictors of the use of 10 presumptively inappropri- 
ate medications used to treat medical conditions among 
nursing home residents, and to use this information to exam- 
ine alternative screening strategies using computerized assess- 
ment data to identify residents who are at  high risk of 
receiving inappropriate medications. 
DESIGN: Retrospective, cross-sectional study. 
PATIENTS: All persons residing in all 252 nursing homes in 
two states during the last 6 months of 1991 ( N  = 21,884). 
MEASUREMENTS: Data were from Minimum Data Set 
Plus (MDS+) assessments, gathered as part of the Health 
Care Financing Administration (HCFA) Multistate Nursing 
Home Casemix and Quality Demonstration Project. The 
MDS+ is an expanded version of the federally mandated 
Minimum Data Set (MDS) that includes additional informa- 
tion on medications and their doses and schedules (frequen- 
cy, standing vs prn). The reliability of the MDS has been 
demonstrated previously. Medications were defined as inap- 
propriate using explicit criteria from published literature. 
Outcome measures were the standing use of each or any of 
10 presumptively inappropriate medications used to treat 
medical (rather than psychiatric or behavioral) conditions. 
Potential predictors of inappropriate medication use included 
patient demographic characteristics, payer, a proxy measure 
for length of stay and admission source, functional status, 
number of standing medications, and state. 
MAIN RESULTS: A total of 12% of residents were pre- 
scribed one or more of 10 presumptively inappropriate med- 
ications on a standing basis, a figure that differed substan- 
tially between states (14.0% vs 7.4% ( P  < .001)). The most 
prevalent inappropriate medications were dipyridamole 
(5.4% of residents), amitriptyline (3.3%), and methyldopa 
(1.8%). Among patients receiving 0 to 3, 4 to 6, and 7+ 
medications, 5%, 12%, and 19%, respectively, were receiv- 
ing at  least one inappropriate medication. In multivariate 
From the ‘Department of Internal Medicine, University of Michigan, the Geriat- 
rics Research Education and Clinical Center, Ann Arbor VA Medical Center, and 
the tDepartment of Health Services Management and Policy, University of Mich- 
igan, Ann Arbor, Michigan. 
Supported, in part, by National Institute of Aging Grant AG08808-05 through 
the University of Michigan Geriatrics Center PilodFeasibility Grants Program. 
Portions presented at the 46th Annual Scientific Meeting of the Gerontological 
Society of America, New Orleans, Louisiana, November 1993. 
Address correspondence to Brent Williams, MD, MPH, University of Michigan 
Medical Center, Dept. of Internal Medicine, Div. of General Medicine, 31 16 
Taubman Center, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0376. 
logistic regression analyses, the strongest predictors of inap- 
propriate medication use were state and the total number of 
standing medications prescribed. Including other statistically 
significant predictors of inappropriate medication use (age > 
65 years, never having been married, severe functional limi- 
tations, being a long-stay patient, and medical diagnosis) did 
not substantially improve the overall predictive ability of the 
model. 
CONCLUSIONS: A substantial proportion of nursing home 
residents receives presumptively inappropriate medications 
to treat medical conditions. Selecting persons prescribed large 
numbers of medications for further review may be the most 
efficient method for nursing home or pharmacy personnel to 
identify residents at  high risk of receiving inappropriate med- 
ications. Extensive additional information on residents’ char- 
acteristics, although widely available through the Minimum 
Data Set, does not significantly improve the ability to identify 
residents receiving inappropriate medications for medical 
conditions. State-specific policies or provider practices also 
influence the likelihood of presumptively inappropriate med- 
ication use among nursing home residents and deserve fur- 
ther investigation. J Am Geriatr SOC 43513-519, 1995. 
hysician care provided to nursing home residents has been P criticized as sporadic, poorly documented, and inade- 
quate to meet residents’ medical needs.’ One aspect of the 
medical care of nursing home residents-the use of sedative/ 
hypnotic and antipsychotic and antidepressant (collectively 
termed psychotropic) medications in the treatment of behav- 
ioral and psychological disorders- has received much atten- 
tion in recent  year^.^.^ Studies have found widespread over- 
use of psychotropic medications in nursing h ~ m e s , Z . ~ - ~  poor
documentation of medical diagnoses for which psychotropic 
medications are indi~ated,~.’ and positive effects of interven- 
tions designed to decrease the use of psychotropic medica- 
tions among nursing home residents8 Partly in response to 
these findings, the use of antipsychotic medications among 
nursing home residents has been the subject of recent federal 
legislation to improve the quality of nursing home care. 
Although psychotropic medications prescribed nursing 
home residents have received much attention, relatively little 
attention has been paid to the appropriateness of medications 
used to treat medical conditions in nursing homes. Since 
nursing home residents commonly receive large numbers of 
medications, many of which are n o n p s y c h ~ t r o p i c , ~ ~ ~  exam- 
ining nonpsychotropic medication use in this population may 
be one method to improve the quality of medical care in 
nursing homes. Identifying instances of inappropriate non- 
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psychotropic medication use among nursing home residents 
has been difficult, however, because (1) judging whether a 
medical regimen is appropriate for a given patient often 
requires detailed knowledge of the patient's medical history, 
which is often lacking in nursing home records, and (2) even 
with perfect medical knowledge about a given patient, widely 
accepted criteria defining appropriate medications have not 
been developed. 
Substantial progress in developing methods to identify 
instances of inappropriate medication use was made by Beers 
and colleagues," who developed, through expert panel con- 
sensus, a list of approximately 30 medications that are pre- 
sumptively inappropriate for nursing home residents. Drugs 
(or drug dosages) were defined as inappropriate if equally 
effective alternative medications were available that had sub- 
stantially lower risk of adverse effects (e.g., chlorpropamide 
for adult-onset diabetes mellitus) or if scientific evidence was 
insufficient to support the use of the medication under any 
circumstances (e.g., isoxsuprine for dementia). One intended 
advantage of these criteria was that any instance of the use of 
the medications (or medication dosages) could be defined as 
(presumptively) inappropriate, allowing the use of comput- 
erized databases, which often lack detailed clinical informa- 
tion, to screen for their use among large groups of nursing 
home residents. 
The purposes of this study were to identify the preva- 
lence and associated patient characteristics of presumptively 
inappropriate nonpsychotropic medication use among nurs- 
ing home residents from two states. Study goals were (1) to 
estimate the "yield" of screening patients' medication profiles 
via computer for inappropriate medications as one potential 
component of a quality assurance system, and (2) to deter- 
mine whether information about patients' demographic, clin- 
ical, and functional characteristics and medical diagnoses 
could be used to identify residents at highest risk of receiving 
inappropriate medications for medical conditions, whose 
medication profiles could then be prioritized for review. This 
latter goal was important to determine whether patients at 
high risk for receiving inappropriate medications could be 
identified using detailed resident information in settings 
where computerized medication information is not available. 
With the widespread implementation of federally mandated 
uniform resident assessments in nursing homes, the ability to 
identify patients at high risk of suboptimal care and to target 
these patients for further review could substantially improve 
the efficiency of quality review efforts. 
METHODS 
Data 
Data were collected as part of the Health Care Financing 
Administration's Multistate Nursing Home Casemix and 
Quality (NHCMQ) Demonstration Project. The purposes of 
the larger project are to develop and implement a case-mix 
payment system (Resource Utilization Groups, Version 111 
[RUG-1111)" and to develop methods to assess quality of care 
in nursing homes. Data for the HCFA Multistate NHCMQ 
Demonstration Project were gathered using an expanded 
version of the Minimum Data Set (MDS), the Minimum Data 
Set Plus (MDS+). The MDS+ was administered to all nurs- 
ing home residents of four states that were centrally involved 
in the NHCMQ Demonstration Project and in several states 
with adjunctive relationships to the project. Implementation 
of the MDS+ began in the four core states in October 1990. 
By July 1, 1991, two of the four states were collecting and 
computerizing data about all residents. Data from these two 
states were used in this study. 
The MDS is a federally mandated assessment instrument 
implemented in nursing homes throughout the United States 
that includes extensive information about patient demo- 
graphic characteristics, functional status, and nursing needs 
relevant to care planning. The development of the MDS has 
been described in more detail elsewhere,12 and the high 
reliability of MDS items has been dem~nstrated.'~-'~ For 
example, among residents of 13 nursing homes in five states 
the interrater reliability (Spearman-Brown intraclass correla- 
tion coefficient) was 0.7 or higher for all items measuring 
activities of daily living (ADL) performance, cognition, con- 
tinence, and total number of  medication^.'^ The MDS+ 
includes all items from the MDS, as well as several additional 
items, including detailed information on all medications used 
by residents. Medication information included type of medi- 
cation, dosage, frequency of administration, and whether 
standing or prn (pro re nata, as necessary). The reliability of 
the detailed medication information available in the MDS+ 
has not been formally determined. Nursing homes were al- 
lowed flexibility in choosing the person or persons to com- 
plete the MDS+ assessments. Commonly, the assessor was 
either the resident's primary nurse or a multidisciplinary 
team of persons with direct responsibility for care of the 
resident. Active medical problems (explicitly defined as con- 
ditions that have a relationship to the resident's functional 
status, cognitive status, behavioral status, medical treat- 
ments, or risk of death) were determined by a registered nurse 
from the medical record and listed on the MDS+ form, either 
in a check-box section containing 31 specific diagnoses or a 
fill-in section for additional diagnoses. Interrater reliabilities 
for check-box diagnoses have been demonstrated to be high, 
(e.g., 0.65,0.69, and 0.80 for depression, stroke, and hyper- 
tension, respectively). l3 However, it is unknown whether the 
implementation of the MDS has affected underreporting of 
medical diagnoses, which has been demonstrated among 
nursing home  resident^.^.' 
Assessments were carried out within 2 weeks of admis- 
sion or readmission to the nursing home, after a significant 
change in clinical status, and no less often than quarterly. 
Data for the study were taken from the most recent 
MDS+ assessment for each nursing home resident in two 
states during the period July 1,1991, to December 31, 1991. 
Data were obtained from 21,884 residents from 252 nursing 
homes. Thus the study population included all patients resid- 
ing in nursing homes as well as all patients admitted (or 
readmitted) to nursing homes of the two states during the last 
6 months of 1991. Approximately three-quarters of the as- 
sessments (n = 15,107) were from one state (hereafter, State 
A), and one-quarter (n = 6777) were from the second state 
(hereafter, State B). Both states requested that states' identi- 
ties remain confidential. 
Data were largely complete and internally consistent. For 
approximately 5 % of residents, demographic data (age, race, 
and gender) and admission source (hospital, home, other 
nursing home, other source) were missing. The proportion of 
assessments with missing data was different between the 
states; approximately 12% of assessments in the smaller state 
(State B) were missing demographic and admission source 
information, compared with approximately 2% of assess- 
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ments in the larger state (State A). For other data elements, 
data were missing for no more than 2% of assessments in 
either state. 
Inappropriate Medications 
Of the 30 inappropriate medications identified by Beers 
et al.,” 10 were included in the present study. Excluded were: 
( 1) anxiolytics and major tranquilizers (psychotropic medi- 
cations), and (2) medications likely to be used on a prn basis 
(e.g., antispasmodics). The latter criteria was included be- 
cause we wished to focus on physician rather than nursing 
behavior and to elucidate relationships between specific med- 
ical conditions and physician prescribing patterns. Amitrip- 
tyline (a psychotropic medication) was included because, 
unlike other psychotropic medications, it is commonly used 
to treat two common medical conditions-urinary inconti- 
nence and peripheral neuropathy. Information on psycho- 
tropic medications (other than amitriptyline) was not in- 
cluded in the data made available for these analyses. 
Predictor Variables 
Resident Demographic Characteristics and 
Functional Status 
Functional status was summarized according to RUG-I11 
ADL Index groups.” This ADL scale combines information 
on patients’ capacity to move around in bed, eat, transfer 
from bed to chair, and get on and off a toilet. The resulting 
score ranges from 4 to 18, with higher scores representing 
increasing levels of impairment. Patients were grouped ac- 
cording to scores 4-7,8-15, and 16-18 inasmuch as nursing 
home residents within these categories have been shown to 
be relatively homogeneous with respect to the time spent by 
nursing staff in caring for them.” In explaining nursing 
time spent in patient-specific activities, the RUG-I11 ADL 
Index performed comparably to the Katz and Barthel ADL 
Inde~es . ’~  
Primary Payer 
Reimbursement for prescription drugs differs substan- 
tially among payers. For example, Medicaid covers prescrip- 
tion drugs, whereas some payers do not. Because the presence 
of a drug benefit has been shown to substantially affect 
prescribing practices,” the relationship of payer and inap- 
propriate medication use was examined. 
Type ofAssessment 
It was important to distinguish inappropriate medication 
use that reflected prescribing patterns in the nursing home 
rather than the residents’ environment before admission 
(most often hospital or home). Residents were classified first 
by the listed indication for the assessment-admission/ 
readmission versus “routine” (quarterly or annual assess- 
ment)-to distinguish recently admitted residents from long- 
stayers. Admittedheadmitted residents (assessed within 14 
days of admission) were then further classified by source of 
admission-hospital, home, or nursing home-to identify 
potential differences in prescribing patterns among these set- 
tings. (Direct information on length of stay, although coded 
in the MDS+, could not be used because of internal incon- 
sistencies in the data for approximately 10% of residents. It 
appeared, for example, that among patients who were hospi- 
talized during their nursing home stay, the date of admission 
to the nursing home was variably coded as the date of original 
admission or date of readmission from the hospital). 
Number of Standing Medications 
We wished to determine whether the prescription of 
large numbers of medications per resident was disproportion- 
ately associated with the receipt of inappropriate medica- 
tions. This type of association would suggest that receiving 
large numbers of medications is a marker for poor prescrib- 
ing practices in general, including prescription of inappropri- 
ate medications. Alternatively, if receipt of inappropriate 
medications was proportionate to the total number of medi- 
cations, this would indicate an exposure effect, whereby 
patients prescribed large numbers of medications are at 
higher risk of inappropriate medications as a result of the 
large number of medications per se rather than because of 
uniquely poor prescribing practices. 
Medical Diagnosis 
Although it is known that medical diagnoses of nursing 
home residents are generally underreported in medical 
records,’ we wished to examine the feasibility of using med- 
ical diagnoses from nursing home medical records (recorded 
in the MDS+) to identify patients receiving inappropriate 
medications in settings in which detailed medication infor- 
mation is not readily available for quality review. 
Statistical Methods 
Bivariate relationships between receipt of inappropriate 
medications and patient characteristics were examined using 
the chi-square test for homogeneity. Multivariate predictors 
of the use of any inappropriate medications were determined 
using logistic regression analyses. In multivariate models, 
demographic variables (age, race, gender, marital status) and 
payer were included in all models. Other variables were 
retained only if they were statistically significant (P < .05). 
The sensitivity of the findings to several factors, particu- 
larly for the multivariate models, was examined in several 
ways. To assess the effects of missing data on the multivariate 
models, observations with missing data were alternatively 
included in the reference category for that variable and ex- 
cluded from the model. Potential clustering effects attribut- 
able to relatively few practitioners prescribing medications in 
each nursing home was examined using the Huber method to 
adjust the standard error estimates in the multivariate mod- 
els.16 Assumptions of logistic regression were examined using 
the Hosmer-Lemeshow test.” 
Statistical analyses were carried out using SASIPC” and 
STATA . 
RESULTS 
The study population was similar to other nursing home 
populations in the United States” (Table 1). The mean (SD) 
age was 82.4 (11.1) years, 73% were female, 16% were 
black, and 65% were widowed. The most important differ- 
ences in resident characteristics between states were that 
23% of the residents in State A (the larger state) were black 
compared with < 1 %  in State B (P < .001), and Medicaid was 
primary payor for 78% of residents in State A versus 47% in 
State B (P < .001). The prevalence of functional limitations 
was high, with 34% of residents requiring active (hands-on) 
human help with eating, 45% with moving around in bed, 
and 65% with toileting. A total of 45% percent of residents 
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Table 1. Characteristics of Nursing Home Residents in Two 
States 
Variable 
Percent of 
Residents 
(N = 21,884)* 
Age (Years) 
<65 
65-74 
75- 84 
85-94 
95 + 
Gender 
Male 
Female 
White 
Black 
Other 
Married 
Single 
Separated, widowed, divorced 
Race 
Marital Status 
Requires active human assistance to 
(may have more than one) 
Eat 
Move around in bed 
Toilet 
Bladder incontinence 
Number of standing medications 
0-3 
4-6 
7-9 
1 o+ 
Admission from hospital 
Admission from home or nursing 
Quarterly assessment 
SelWprivate insurance 
Medicare 
Medicaid 
Type of assessment** 
home 
Payer (may have more than one) 
Selected medical diagnoses (may 
have more than one) 
Depression 
Peripheral neuropathy 
Stroke 
Hypertension 
Number of inappropriate standing 
medications 
None 
One 
Two or three 
6.7 
12.7 
35.0 
37.8 
7.7 
26.8 
73.2 
82.3 
16.4 
1.4 
15.5 
14.1 
70.4 
34.3 
45.2 
64.9 
44.8 
31.5 
37.5 
21.5 
9.5 
13.3 
6.6 
80.1 
47.2 
4.7 
63.1 
9.3 
0.4 
25.0 
33.6 
88.1 
11.2 
0.7 
*Percentages exclude missing values; see text for details. 
“See text for definitions. 
were incontinent of bladder at  least twice a week. The mean 
(SD) number of standing (non-prn) medications prescribed 
was 5.2 (3.1), a value that did not vary between the states. 
Approximately 20% of patients had admissionheadmission 
assessments and, thus, had resided in the nursing home less 
than 2 weeks. Of these, roughly three-quarters were admit- 
tedheadmitted from the hospital. 
A total of 12% of residents received at least one of 10 
inappropriate medications (Table 2). By far the most com- 
mon inappropriate medications were dipyridamole, amitrip- 
tyline, and methyldopa. Each of the remaining seven medica- 
tions or medication dosages was prescribed for less than 1 Yo 
of residents. The large majority of patients receiving any 
inappropriate medications received only one, with only 0.7% 
of patients receiving two or three inappropriate medications 
(Table 1). 
Differences in the proportions of residents in the two 
states who were prescribed each inappropriate medication or 
any inappropriate medication were substantial. For example, 
proportionately twice as many residents of State A were 
prescribed inappropriate medications compared with State B 
(14 vs 7%, P < . O O l ) .  However, the relative prevalence of 
inappropriate medications was similar between the states, 
with dipyridamole, amitriptyline, and methyldopa the three 
most common inappropriate medications in both states. 
Total Number of Standing Medications and the Use of 
Inappropriate Medications 
The likelihood of receiving any inappropriate medica- 
tion was strongly positively associated with increasing num- 
bers of standing medications (Figure 1). For example, only 
5.4% of patients receiving 0 to 3 standing medications (32% 
of the population) were receiving at  least one inappropriate 
medication, whereas 22.3% of persons receiving 10 or more 
medications (10% of the population) were receiving at  least 
one inappropriate medication. 
Medical Diagnoses and the Use of 
Inappropriate Medications 
The use of inappropriate medications was associated 
with the documented presence of specific medical diagnoses. 
Among the 1181 patients receiving dipyridamole, 581 (49%) 
had a documented diagnosis of stroke (cerebrovascular acci- 
dent or transient ischemic attack); of the 396 patients receiv- 
ing methyldopa, 317 (80%) had a diagnosis of hypertension; 
and of the 714 patients prescribed amitriptyline, 444 (62%) 
Table 2. Prevalence of Presumptively Inappropriate Medications 
Among Nursing Home Residents 
Percent of 
Residents 
Medication (N = 21,884) 
Dipyridamole 
Amitriptyline 
Methyldopa 
Reserpine 
Chlorpropamide 
Cimetidine > 900 mg/day 
Hydrochlorothiazide > 50 mg/day 
Ranitidine > 300 mg/day 
Cyclandelate 
Isoxsuprine 
Any inappropriate medication 
5.4 
3.3 
1.8 
0.8 
0.5 
0.4 
0.1 
0.1 
0.1 
0.1 
12.0 
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25 
22.3 Table 3. Logistic Regression Model Predicting Receipt of Any Inappropriate Medication a 
17.3 
15 - 
11.6 
b 
5.4 
0 
Odds 
Ratio 
(95% Conf. 
Interval) Predictors 
Age 
Age less than 65 
Age 65-84 
Age 85 or greater 
Gender 
Female 
Male 
White 
Black 
Other, non-black 
Marital status 
Widowed, separated, divorced 
Married 
Never married 
Type of assessment 
Admission from hospital 
Admission from home or nursing 
Quarterly assessment 
Medicaid payment 
Race 
home 
Payment source 
No 
Yes 
No 
Yes 
No 
Yes 
Self-pay or private insurance 
Medicare payment 
Standing medications 
3 or fewer 
7 or more 
4 -7 
8-15 
16 or more 
State A 
State B 
4-6 
RUG-Ill ADL Index' 
State 
0.75 
1 .oo 
0.94 
(0.60, 0.94) 
(0.85, 1.03) 
1 .oo 
0.90 (0.80, 1.01) 
0-3 4-6 7-9 lo+ 
Number of standing mediations 
Figure 1. Relationship between receipt of any inappropriate 
medication and number of standing medications (N = 21,884). 
1 .oo 
0.90 
0.96 
(0.79, 1.04) 
(0.62, 1.46) 
1 .oo 
1 .oo 
0.82 
(0.88, 1.16) 
(0.70, 0.96) had a diagnosis of depression, peripheral neuropathy, or 
were incontinent of urine. 
Conversely, the presence of selected medical diagnoses 
was not a very efficient method for identifying the use of 
inappropriate medications. For example, only 10% of pa- 
tients with the documented diagnosis of stroke received di- 
pyridamole; only 4% of patients with the diagnosis of hyper- 
tension received methyldopa; and only 3% of patients with 
the diagnosis of depression, peripheral neuropathy, or uri- 
nary incontinence received amitriptyline. 
MultivariateModels Predicting Use ofAny 
Inappropriate Medication 
The strongest bivariate predictors-total number of 
standing medications and state-persisted in multivariate 
models that controlled for patient age, gender, race, marital 
status, source of admission, payer, and functional status 
(Table 3). 
There was a generally linear relationship between 
the total number of standing medications and the likelihood 
of receiving an inappropriate medication, though this 
effect leveled off somewhat at around 10 to 12 medications 
in multivariate models. Since only 10% of patients received 
10 or more medications, patients with seven or more 
standing medications were classified together in multivariate 
models. The odds of receiving at least one inappropriate 
medication among persons receiving 4 to 6 or 7 or more 
standing medications were 2.2 and 3.8 times higher, respec- 
tively, than among persons receiving 0 to 3 standing medica- 
tions. 
State remained a strong predictor of the use of any 
inappropriate medication, with residents of State B only half 
as likely as residents of State A to receive at least one inap- 
propriate medication. 
Receiving one or more inappropriate medication was 
also associated with age greater than 65, female gender, being 
single (never married), having a quarterly assessment (a 
proxy for long nursing home stay), and having severe func- 
tional limitations. Black race was negatively and receipt of 
Medicaid was positively associated with inappropriate med- 
ication use, but these associations were not statistically sig- 
nificant. 
1 .oo 
1.01 (0.79, 1.29) 
(0.99, 1.33) 1.15 
1 .oo 
1.09 (0.96, 1.23) 
1 .oo 
1.01 (0.91, 1.12) 
1 .oo 
1.17 (0.94, 1.45) 
1 .oo 
2.18 
3.81 
(1.90, 2.50) 
(3.30, 4.40) 
1 .oo 
1 .oo 
0.82 
(0.90, 1.1 0) 
(0.71, 0.95) 
1 .oo 
0.48 (0.43, 0.54) 
Number of obs = 17,661 
Log likelihood = -6149.86 
,$(17) = 703.29 
Pseudo R2 = 0.054 
'RUG-I11 is Resource Utilization Groups, version 3. See text for definition; 
higher levels denote greater functional limitation. Includes information on bed 
mobility, eating, transferring, and toileting. 
Interaction terms were examined among demographic 
characteristics, primary payer, and functional status. None 
was significant, except for being black and on Medicaid, 
which were associated with increased likelihood of receiving 
inappropriate medications (P = .04). Inclusion of this term in 
the multivariate model did not substantially affect the re- 
maining odds ratios in the model. 
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The multivariate model had a high sensitivity but low 
specificity for identifying persons receiving inappropriate 
medications. For example, using a predicted probability of 
0.1 as the cutoff, 75% of persons with and 53% of persons 
without inappropriate medications were correctly identified 
by the full model. This was comparable to the performance of 
a restricted model, which included only information on the 
number of standing medications and state, that correctly 
identified 79% of persons with and 46% of persons without 
inappropriate medications. 
The main findings of the multivariate models were insen- 
sitive to whether patients with missing values were included 
in the reference categories for the relevant variables and to 
application of the Huber correction for cluster effects with 
nursing homes. 
DISCUSSION 
The prevalence of inappropriate medications used to 
treat medical conditions among nursing home residents in 
two states was substantial, with nearly one in eight residents 
receiving at  least one of 10 selected inappropriate medica- 
tions. This prevalence is consistent with that found by Beers 
and colleagues2' for the same medications in 12 nursing 
homes in California during the same period. However, Beers 
et al. reported the rate of inappropriate medication use as a 
percent of all prescriptions rather than percent of patients, 
making direct comparisons difficult. The total prevalence of 
inappropriate medication use is likely to be much higher in 
our study population, because psychotropic (other than am- 
itriptyline) and prn medications were not included. With the 
prevalence of inappropriate medication use this high, screen- 
ing all residents for the presence of one or more presump- 
tively inappropriate medications in nursing homes with ac- 
cess to computerized medication profiles would result in a 
reasonable "hit rate." To make the system more efficient, or 
in nursing homes without access to computerized informa- 
tion on medications, patients prescribed large numbers (e.g., 
more than six standing or eight total medications) of medi- 
cations could be targeted for review. In this population, 
among residents receiving seven or more standing medica- 
tions (31% of residents), 19% received at least one inappro- 
priate medication. Information on the total number of med- 
ications used by residents is recorded on the MDS. Using 
other information routinely available from MDS assessments 
among nursing home residents is unlikely to improve sub- 
stantially the ability to identify residents at high risk for use of 
inappropriate medications for medical conditions. 
Once patients receiving presumptively inappropriate 
medications are identified, several courses of action could be 
taken. The prescribing physician could be contacted with the 
recommendation that the medication be stopped or changed 
to a safer alternative. If resources permit, information from 
the medical literature could be provided as well to justify this 
recommendation. Physicians have responded positively to 
academic detailing of this type.8 
A twofold difference in the prevalence of presumptively 
inappropriate medications between the two states was ob- 
served. This difference could be attributable to state-specific 
policies that affect prescribing patterns in nursing homes, 
regional differences in prescribing habits, or both. Future 
studies should investigate factors that could account for such 
large regional variations in the use of particular medications 
among nursing home residents. 
One goal of the present study was to determine the 
usefulness of information on patient characteristics in identi- 
fying persons most likely to receive inappropriate medica- 
tion. This seemed important because a large amount of de- 
tailed information is now widely available on nursing home 
residents, through the implementation of the MDS, and is 
becoming increasingly computerized, whereas detailed in for- 
mation on medications is not uniformly readily available for 
central review. After accounting for the total number of 
medications and state, including information on other patient 
characteristics did not significantly improve the ability to 
identify persons receiving inappropriate medications. This 
substantially simplifies the use of MDS information (which 
includes information on the total number of medications) in 
identifying patients who are most likely to benefit from 
detailed medication review. 
The mean (SD) number of standing medications in the 
two states examined was 5.2 (3.1), which is similar to other 
nursing home populations described over the past 2 de- 
cade~.' .~ Thus, despite extensive documentation of the extent 
of polypharmacy among nursing home residents, the problem 
remains significant. 
A definite but imperfect relationship between relevant 
medical diagnoses and the use of inappropriate medications 
was present in the study population. That is, a substantial 
proportion (20-40%) of patients receiving inappropriate 
medications did not have medical diagnoses associated with 
the medication. This was best demonstrated in the case of 
methyldopa. Fully 20% of persons receiving methyldopa 
did not have a diagnosis of hypertension recorded in the 
medical record (as reflected in the MDS+), yet treatment of 
hypertension is the only medical indication for this medica- 
tion. Thus, it is likely that the problem of underreporting 
medical conditions in the nursing home medical record per- 
sists and that diagnostic information is of little value in 
identifying residents at  high risk of receiving inappropriate 
medications. 
The associations of inappropriate medication use and 
other patient characteristics were generally similar to the 
positive associations reported between psychotropic medica- 
tions in nursing homes and advanced and female 
gender9v2' and the lack of association between receipt of 
Medicaid and inappropriate medication use.21 
A strength of the present study is its focus on standing 
rather than prn medications. Most previous studies have not 
made this distinction,'V2' which has made it difficult to sepa- 
rate physician from nursing behavior in administration of 
inappropriate medications in nursing homes. The medica- 
tions examined in the present study are prescribed by physi- 
cians only on a standing basis. Therefore, any actual use is 
solely the responsibility of the physician. 
The primary limitation of this study is that the mere 
presence of a presumptively inappropriate medication does 
not necessarily demonstrate that suboptimal care is being 
provided or that adverse clinical outcomes are likely. One 
way to overcome this problem would be to focus on medica- 
tions with no scientifically demonstrated benefit. Such un- 
proven medications may have the greatest potential for use in 
identifying persons receiving poor quality medical care. 
However, of the medications examined here that have no 
scientifically demonstrated benefit (dipyridamole, cyclande- 
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late, and isoxsuprine), only one (dipyridamole) occurred 
among more than 0.10% of patients. In addition, to our 
knowledge, the incidence of adverse clinical consequences 
associated with the use of dipyridamole among nursing home 
residents has not been demonstrated. 
Other medications, which have proven benefit but high 
toxicity profiles relative to alternatives, may not, in fact, 
be inappropriate in every case (e.g., methyldopa at low doses, 
reserpinez3). At present, however, few explicitly derived 
criteria exist for defining inappropriate medications among 
nursing home residents, and very little data exist linking 
the use of particular medications to adverse clinical out- 
comes. Until such data are available, the approach taken here 
may remain the most efficient way to identify for further 
review patients at  risk for poor medication prescribing prac- 
tices. 
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